TRIM33 and myositis disease: established a TIF1γ-induced myositis model (TIM) in B6 mice via weekly subcutaneous injections of recombinant human TIF1γ protein emulsified in CFA four times, along with an intraperitoneal injection of pertussis toxin (PT) (16).